SEC 13F Intelligence

Managers / Q4 2024 · view latest →

Sivik Global Healthcare LLC

CIK 0001596452 · 133 TACONIC RD, GREENWICH, CT, 06831 · 203-769-8600

Reported Value
$190M
Q4 2024
Positions
38
Filings on Record
30
2019–present window
Filed
Jan 23, 2025
original filing

Summary

Sivik Global Healthcare LLC reported $190M in U.S.-listed holdings across 38 positions for Q4 2024.

Its largest position, XBI, represents 9.5% of the portfolio.

Compared with Q3 2024, the fund opened 13 new positions and exited 10.

Portfolio Metrics

Turnover
+22.4%
vs prior filed quarter
Top-10 Concentration
+45.9%
share of reported value
Largest Position
+9.5%
Spdr S P Biotech Etf
New / Exited
13 / 10
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $186MQ4 ’18Q1 ’19: $271MQ2 ’19: $414MQ3 ’19: $198MQ4 ’19: $269MQ4 ’19Q1 ’20: $253MQ2 ’20: $302MQ3 ’20: $232MQ4 ’20: $245MQ4 ’20Q1 ’21: $274MQ2 ’21: $512MQ3 ’21: $419MQ4 ’21: $233MQ4 ’21Q1 ’22: $242MQ2 ’22: $176MQ3 ’22: $180MQ4 ’22: $213MQ4 ’22Q1 ’23: $233MQ2 ’23: $428MQ3 ’23: $198MQ4 ’23: $239MQ4 ’23Q1 ’24: $427MQ2 ’24: $278MQ3 ’24: $236MQ4 ’24: $190MQ4 ’24Q1 ’25: $185MQ2 ’25: $368MQ3 ’25: $344MQ4 ’25: $345MQ4 ’25Q1 ’26: $132Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 84.8%ETP: 9.5%ADR: 5.7%
  • Common Stock · 84.8% · $161M
  • ETP · 9.5% · $18M
  • ADR · 5.7% · $11M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
UNHUNITEDHEALTH GRPNEW+12.5K12.5K+$6M$6M
WATWATERS CORPNEW+14.0K14.0K+$5M$5M
AAGILENT TECHNOLOGIES INCNEW+35.0K35.0K+$5M$5M
ABBVABBVIE INCNEW+25.0K25.0K+$4M$4M
BMYBRISTOL-MYERS SQUIBB CONEW+70.0K70.0K+$4M$4M
EWEDWARDS LIFESCIENCESNEW+50.0K50.0K+$4M$4M
CICIGNA GROUP/THENEW+12.0K12.0K+$3M$3M
BIOBIO-RAD LABS ANEW+10.0K10.0K+$3M$3M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2024

36 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1XBISPDR S&P BIOTECH ETFhistory →S&P BIOTECH9.48%$18M200.0K
2LLYELI LILLY & COhistory →COM6.10%$12M15.0K
3BSXBOSTON SCIENTIFIC CORPORATIONhistory →COM5.17%$10M110.0K
4MCKMCKESSON CORPhistory →COM4.50%$9M15.0K
5SYKSTRYKER CORPhistory →COM3.79%$7M20.0K
6THCTENET HEALTHCAREhistory →COM CL A3.66%$7M55.0K
7UHSUNIV HEALTH SVChistory →SPDN ADR NEW3.54%$7M37.5K
8UNHUNITEDHEALTH GRPhistory →COM3.33%$6M12.5K
9NVONOVO-NORDISK A/Shistory →COM3.17%$6M70.0K
10HCAHCA HEALTHCARE INChistory →COM3.16%$6M20.0K
11CAHCARDINAL HEALTHhistory →COM3.11%$6M50.0K
12DHRDANAHER CORPhistory →COM3.02%$6M25.0K
13ABTABBOTT LABShistory →COM NEW2.98%$6M50.0K
14CORCENCORA INChistory →COM2.96%$6M25.0K
15VRTXVERTEX PHARMACEUTICALS INC.history →COM2.76%$5M13.0K
16WATWATERS CORPhistory →COM2.74%$5M14.0K
17HUMHUMANA INC.history →COM2.67%$5M20.0K
18AAGILENT TECHNOLOGIES INChistory →COM NEW2.48%$5M35.0K
19ABBVABBVIE INChistory →COM2.34%$4M25.0K
20SGRYSURGERY PARTNERS INChistory →COM2.23%$4M200.0K
21AVTRAVANTOR INChistory →SPONSORED ADS2.22%$4M200.0K
22EHCENCOMPASS HEALTH CORPhistory →COM2.19%$4M45.0K
23BMYBRISTOL-MYERS SQUIBB COhistory →COM2.08%$4M70.0K
24EWEDWARDS LIFESCIENCEShistory →COM1.95%$4M50.0K
25CICIGNA GROUP/THEhistory →COM1.75%$3M12.0K
26BIOBIO-RAD LABS Ahistory →CLASS B1.73%$3M10.0K
27SNNSMITH & NEPHEWhistory →COM1.62%$3M125.0K
28S24SELECT MEDICAL HOLDINGS CORPhistory →COM1.49%$3M150.0K
29ZTSZOETIS INChistory →COM1.29%$2M15.0K
30ZBHZIMMER BIOMET HOLDINGS INChistory →COM1.11%$2M20.0K
31ACHCACADIA HEALTHCREhistory →CL A1.04%$2M50.0K
32BNTXBIONTECH SECOM0.90%$2M15.0K
33ALNYALNYLAM PHARMACEUTICALSCL A0.87%$2M7.0K
34RGENREPLIGEN CORPCOM0.76%$1M10.0K
35SRPTSAREPTA THERAPEUTICS INCADR0.64%$1M10.0K
36MRVIMARAVAI LIFESCIENCES HLDGS-ACOM0.40%$763,000140.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$132M34Apr 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$345M49Jan 21, 202613F-HRchanges · EDGAR ↗
Q3 2025$344M44Oct 23, 202513F-HRchanges · EDGAR ↗
Q2 2025$368M46Jul 25, 202513F-HRchanges · EDGAR ↗
Q1 2025$185M31Apr 22, 202513F-HRchanges · EDGAR ↗
Q4 2024$190M38Jan 23, 202513F-HRchanges · EDGAR ↗
Q3 2024$236M35Nov 6, 202413F-HRchanges · EDGAR ↗
Q2 2024$278M38Jul 29, 202413F-HRchanges · EDGAR ↗
Q1 2024$427M47May 1, 202413F-HRchanges · EDGAR ↗
Q4 2023$239M39Feb 5, 202413F-HRchanges · EDGAR ↗
Q3 2023$198M33Nov 7, 202313F-HRchanges · EDGAR ↗
Q2 2023$428M43Aug 9, 202313F-HRchanges · EDGAR ↗
Q1 2023$233M40May 8, 202313F-HRchanges · EDGAR ↗
Q4 2022$213M39Feb 8, 202313F-HRchanges · EDGAR ↗
Q3 2022$180M41Nov 4, 202213F-HRchanges · EDGAR ↗
Q2 2022$176M38Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$242M49May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$233M45Feb 8, 202213F-HRchanges · EDGAR ↗
Q3 2021$419M43Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$512M49Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$274M47May 12, 202113F-HRchanges · EDGAR ↗
Q4 2020$245M38Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$232M38Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$302M52Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$253M40May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$269M50Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$198M45Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$414M62Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$271M61May 8, 201913F-HRchanges · EDGAR ↗
Q4 2018$186M48Feb 12, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.